Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Targeting the Coronavirus Nucleocapsid Protein through GSK-3 Inhibition

Xiaolei Liu, Anurag Verma, Holly Ramage, View ORCID ProfileGustavo Garcia Jr., Rebecca L. Myers, Anastasia Lucas, View ORCID ProfileJacob J. Michaelson, William Coryell, Arvind Kumar, Alexander Charney, Marcelo G. Kazanietz, Daniel J Rader, Marylyn D Ritchie, Wade H. Berrettini, Robert Damoiseaux, Vaithilingaraja Arumugaswami, David Schultz, Sara Cherry, View ORCID ProfilePeter S. Klein
doi: https://doi.org/10.1101/2021.02.17.21251933
Xiaolei Liu
1Department of Medicine, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anurag Verma
1Department of Medicine, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA, USA.
2Department of Genetics, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Holly Ramage
3Department of Microbiology, Perelman School od Medicine, University of Pennsylvania, Philadelphia, PA, USA. Current position: Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gustavo Garcia Jr.
4Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gustavo Garcia Jr.
Rebecca L. Myers
5Pharmacology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anastasia Lucas
2Department of Genetics, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacob J. Michaelson
6Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jacob J. Michaelson
William Coryell
6Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arvind Kumar
7Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander Charney
8Departments of Psychiatry, Neurosurgery, Neuroscience, and Genetics and Genomic Sciences, Friedman Brain Institute, and Icahn Institute of Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcelo G. Kazanietz
9Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel J Rader
1Department of Medicine, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA, USA.
2Department of Genetics, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marylyn D Ritchie
2Department of Genetics, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wade H. Berrettini
10Center for Neurobiology and Behavior, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Damoiseaux
4Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vaithilingaraja Arumugaswami
4Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Schultz
11Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara Cherry
3Department of Microbiology, Perelman School od Medicine, University of Pennsylvania, Philadelphia, PA, USA. Current position: Department of Microbiology and Immunology, Thomas Jefferson University, Philadelphia, PA, USA.
11Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
12Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter S. Klein
1Department of Medicine, Perelman School of Medicine, University of Pennsylvania; Philadelphia, PA, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Peter S. Klein
  • For correspondence: pklein@pennmedicine.upenn.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

The coronaviruses responsible for severe acute respiratory syndrome (SARS-CoV), COVID-19 (SARS-CoV-2), Middle East respiratory syndrome (MERS-CoV), and other coronavirus infections express a nucleocapsid protein (N) that is essential for viral replication, transcription, and virion assembly. Phosphorylation of N from SARS-CoV by glycogen synthase kinase 3 (GSK-3) is required for its function and inhibition of GSK-3 with lithium impairs N phosphorylation, viral transcription, and replication. Here we report that the SARS-CoV-2 N protein contains GSK-3 consensus sequences and that this motif is conserved in diverse coronaviruses, despite limited overall sequence conservation, raising the possibility that SARS- CoV-2 may be sensitive to GSK-3 inhibitors including lithium. We conducted a retrospective analysis of lithium use in patients from three major health systems who were PCR tested for SARS-CoV-2. We found that patients taking lithium have a significantly reduced risk of COVID- 19 (odds ratio = 0.51 [0.34 - 0.76], p = 0.001). We also show that the SARS-CoV-2 N protein is phosphorylated by GSK-3. Knockout of GSK3A and GSK3B demonstrates that GSK-3 is essential for N phosphorylation. Alternative GSK-3 inhibitors block N phosphorylation and impair replication in SARS-CoV-2 infected lung epithelial cells in a cell-type dependent manner.

Targeting GSK-3 may therefore provide a new approach to treat COVID-19 and future coronavirus outbreaks.

Competing Interest Statement

The authors declare no competing interests. MDR is on the Scientific Advisory Board for Goldfinch Bio and Cipherome.

Funding Statement

PSK is supported by grants from the National Institutes of Health (1R01HL141759 and 1R01GM115517). VA is supported by the UCLA DGSOM and Broad Stem Cell Research Center institutional award (OCRC #20-15), National Institute of Health (1R01EY032149), and the California Institute for Regenerative Medicine TRAN Award (TRAN1COVID19-11975). We thank the Dean’s Innovation Fund, Linda and Laddy Montague, BWF, NIAID (5R01AI140539, 1R01AI1502461, R01AI152362), NCATS, the Fast Grants Award from Mercatus, and the Bill and Melinda Gates Foundation for funding to SC. SC is an Investigator in the Pathogenesis of Infectious Diseases from the Burroghs Wellcome Fund.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

EHR analysis was performed with Institutional Review Board (IRB) approval from the University of Pennsylvania (IRB #844360) and the Mt. Sinai Medical Center (IRB #20-00338).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • ↵† These authors contributed equally to this work.

Data Availability

Data are available upon request from the authors. Electronic Health Record data are available upon request from qualified investigators subject to a data use agreement and IRB approval.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted February 22, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Targeting the Coronavirus Nucleocapsid Protein through GSK-3 Inhibition
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Targeting the Coronavirus Nucleocapsid Protein through GSK-3 Inhibition
Xiaolei Liu, Anurag Verma, Holly Ramage, Gustavo Garcia Jr., Rebecca L. Myers, Anastasia Lucas, Jacob J. Michaelson, William Coryell, Arvind Kumar, Alexander Charney, Marcelo G. Kazanietz, Daniel J Rader, Marylyn D Ritchie, Wade H. Berrettini, Robert Damoiseaux, Vaithilingaraja Arumugaswami, David Schultz, Sara Cherry, Peter S. Klein
medRxiv 2021.02.17.21251933; doi: https://doi.org/10.1101/2021.02.17.21251933
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Targeting the Coronavirus Nucleocapsid Protein through GSK-3 Inhibition
Xiaolei Liu, Anurag Verma, Holly Ramage, Gustavo Garcia Jr., Rebecca L. Myers, Anastasia Lucas, Jacob J. Michaelson, William Coryell, Arvind Kumar, Alexander Charney, Marcelo G. Kazanietz, Daniel J Rader, Marylyn D Ritchie, Wade H. Berrettini, Robert Damoiseaux, Vaithilingaraja Arumugaswami, David Schultz, Sara Cherry, Peter S. Klein
medRxiv 2021.02.17.21251933; doi: https://doi.org/10.1101/2021.02.17.21251933

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (166)
  • Anesthesia (49)
  • Cardiovascular Medicine (447)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (188)
  • Epidemiology (5196)
  • Forensic Medicine (3)
  • Gastroenterology (192)
  • Genetic and Genomic Medicine (746)
  • Geriatric Medicine (76)
  • Health Economics (210)
  • Health Informatics (689)
  • Health Policy (350)
  • Health Systems and Quality Improvement (221)
  • Hematology (98)
  • HIV/AIDS (161)
  • Infectious Diseases (except HIV/AIDS) (5788)
  • Intensive Care and Critical Care Medicine (353)
  • Medical Education (101)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (754)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (140)
  • Occupational and Environmental Health (230)
  • Oncology (473)
  • Ophthalmology (149)
  • Orthopedics (37)
  • Otolaryngology (93)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (138)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (135)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (851)
  • Public and Global Health (1983)
  • Radiology and Imaging (340)
  • Rehabilitation Medicine and Physical Therapy (154)
  • Respiratory Medicine (282)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (74)
  • Surgery (107)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)